Skip to main content

Tumors of the Heart & Lung

Tumors of the Heart & Lung
Tumors of the Heart & Lung

Tumors of the heart and lung can be either benign (non-cancerous) or malignant (cancerous). Cardiac tumors are rare, with an incidence of less than 0.1% in autopsy series. Lung tumors are among the most common cancers worldwide.

Cardiac Tumors

Primary cardiac tumors are extremely rare. The most common benign cardiac tumor is myxoma, which typically occurs in the left atrium. Malignant cardiac tumors include sarcomas, which are aggressive and have a poor prognosis.

Secondary (metastatic) tumors of the heart are much more common than primary tumors, occurring in approximately 10% of patients with widespread cancer.

Lung Tumors

Lung cancer is one of the most common cancers worldwide and the leading cause of cancer death. The two main types are:

  • Non-Small Cell Lung Cancer (NSCLC) — The most common type, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma
  • Small Cell Lung Cancer (SCLC) — A more aggressive type that spreads quickly
Symptoms
  • Persistent cough or change in cough
  • Chest pain that worsens with deep breathing
  • Shortness of breath
  • Coughing up blood
  • Unexplained weight loss
  • Fatigue and weakness
Treatment

Treatment depends on the tumor type, location, and stage:

  • Surgical resection is the primary treatment for localized tumors
  • Chemotherapy and radiation therapy
  • Targeted therapy and immunotherapy for specific tumor types
  • Video-Assisted Thoracic Surgery (VATS) for minimally invasive lung procedures
Tags:
Dr. Clyde Yancy

About Author

Dr. Clyde Yancy
Cardiologist

Dr. Clyde Warren Yancy is an American cardiologist and the Magerstadt Professor at Northwestern University Feinberg School of Medicine, Past President of the American Heart Association.

ONLINE HASSLE FREE Appointment BOOKING

Get an appointment with us and get the resolution ASAP
Book Your Appointment

This website uses cookies to improve your experience. By continuing to browse, you accept our use of cookies.